Literature DB >> 20690147

Global analysis of in vivo EGR1-binding sites in erythroleukemia cell using chromatin immunoprecipitation and massively parallel sequencing.

Chao Tang1, Xiaolong Shi, Wei Wang, Dequan Zhou, Jing Tu, Xueying Xie, Qinyu Ge, Peng Feng Xiao, Xiao Sun, Zuhong Lu.   

Abstract

Early growth response gene 1 (EGR1) has been implicated in megakaryocyte differentiation induced by phorbol ester. But the molecule mechanism of EGR1 in this process has not been widely investigated. The identification of direct EGR1 target genes in a global scale is critical for our understanding of how EGR1 contributes to this process. In this study, we provide a global survey on the binding location of EGR1 in the K562 cells using chromatin immunoprecipitation and massively parallel sequencing. Over 14 000 highly confident in vivo EGR1 binding sites were identified in phorbol 12-myristate 13-acetate-treated K562 cells. More than 70% of these genomic sites associated with EGR1 binding were located around annotated gene regions. Molecular functional classification of 6138 putative EGR1 target genes showed that the transcription factor class (695 of 6138; 11%) is the largest significantly enriched one. The results showed that a high coverage of the genome and a high positive rate achieve were achieved. This whole genome study on the EGR1 targets may provide a better understanding of the EGR1 regulated genes and the downstream pathway in megakaryocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20690147     DOI: 10.1002/elps.201000094

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  8 in total

1.  EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.

Authors:  Gabi Tarcic; Roi Avraham; Gur Pines; Ido Amit; Tal Shay; Yiling Lu; Yaara Zwang; Menachem Katz; Nir Ben-Chetrit; Jasmine Jacob-Hirsch; Laura Virgilio; Gideon Rechavi; George Mavrothalassitis; Gordon B Mills; Eytan Domany; Yosef Yarden
Journal:  FASEB J       Date:  2011-12-23       Impact factor: 5.191

2.  Genome-wide approaches reveal EGR1-controlled regulatory networks associated with neurodegeneration.

Authors:  Radosveta Koldamova; Jonathan Schug; Martina Lefterova; Andrea A Cronican; Nicholas F Fitz; Faith A Davenport; Alexis Carter; Emilie L Castranio; Iliya Lefterov
Journal:  Neurobiol Dis       Date:  2013-11-20       Impact factor: 5.996

3.  Mechanisms of dietary response in mice and primates: a role for EGR1 in regulating the reaction to human-specific nutritional content.

Authors:  Kai Weng; Haiyang Hu; Augix Guohua Xu; Philipp Khaitovich; Mehmet Somel
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

4.  Global Egr1-miRNAs binding analysis in PMA-induced K562 cells using ChIP-Seq.

Authors:  Wei Wang; Dequang Zhou; Xiaolong Shi; Chao Tang; Xueying Xie; Jing Tu; Qinyu Ge; Zuhong Lu
Journal:  J Biomed Biotechnol       Date:  2010-08-03

5.  Haemodynamically dependent valvulogenesis of zebrafish heart is mediated by flow-dependent expression of miR-21.

Authors:  Toshihiro Banjo; Janin Grajcarek; Daisuke Yoshino; Hideto Osada; Kota Y Miyasaka; Yasuyuki S Kida; Yosuke Ueki; Kazuaki Nagayama; Koichi Kawakami; Takeo Matsumoto; Masaaki Sato; Toshihiko Ogura
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Identification of egr1 direct target genes in the uterus by in silico analyses with expression profiles from mRNA microarray data.

Authors:  Bong-Jong Seo; Ji Won Son; Hye-Ryun Kim; Seok-Ho Hong; Haengseok Song
Journal:  Dev Reprod       Date:  2014-03

7.  High-throughput functional comparison of promoter and enhancer activities.

Authors:  Thomas A Nguyen; Richard D Jones; Andrew R Snavely; Andreas R Pfenning; Rory Kirchner; Martin Hemberg; Jesse M Gray
Journal:  Genome Res       Date:  2016-06-16       Impact factor: 9.043

8.  Large-scale quality analysis of published ChIP-seq data.

Authors:  Georgi K Marinov; Anshul Kundaje; Peter J Park; Barbara J Wold
Journal:  G3 (Bethesda)       Date:  2014-02-19       Impact factor: 3.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.